Effect of High-Intensity Laser Therapy on Femoral Cartilage in Knee Osteoarthritis
HILT-KOA
The Role of High-intensity Laser Therapy on Femoral Cartilage Thickness in Patients With Knee Osteoarthritis
1 other identifier
interventional
58
1 country
1
Brief Summary
This clinical trial will evaluate the effects of High-Intensity Laser Therapy (HILT) on femoral cartilage thickness and other clinical outcomes in people with knee osteoarthritis. Participants aged 40 to 60 years with grade II or III knee osteoarthritis will be randomly assigned to receive either HILT plus conventional physiotherapy or conventional physiotherapy alone. Both groups will receive 12 treatment sessions on alternate days for 4 weeks. The study will assess changes in cartilage thickness using ultrasound, as well as improvements in pain, knee movement, muscle strength, and daily function. Findings from this research may help improve physiotherapy treatment strategies for patients with knee osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2027
Study Completion
Last participant's last visit for all outcomes
May 10, 2027
May 13, 2026
May 1, 2026
7 months
November 17, 2025
May 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Femoral Cartilage Thickness
Mean change in femoral cartilage thickness (mm) measured by high-frequency musculoskeletal ultrasound at three standardized sites - medial femoral condyle, intercondylar notch, and lateral femoral condyle. The measurement will be performed using a 7-12 MHz linear probe following standardized scanning protocol
Baseline, Week 4
Secondary Outcomes (5)
Pain Intensity
Baseline, Week 2, Week 4
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Baseline, Week 2, Week 4
Knee Range of Motion (ROM)
Baseline, Week 2, Week 4
One-Leg Stance Test
Baseline, Week 2, Week 4
Quadriceps Muscle Strength
Baseline, Week 2, Week 4
Study Arms (2)
High-Intensity Laser Therapy (HILT) + Conventional Physiotherapy
EXPERIMENTALParticipants in this group will receive High-Intensity Laser Therapy (HILT) using a Class IV laser (1064 nm wavelength) applied at eight standardized knee points according to WALT guidelines, along with conventional physiotherapy including hot moist pack, joint mobilization, and strengthening exercises. Treatment will be given on alternate days for 4 weeks (12 sessions total).
Conventional Physiotherapy
ACTIVE COMPARATORParticipants in this group will receive only conventional physiotherapy, including hot moist pack, patellofemoral and tibiofemoral joint mobilization, and a structured exercise program for quadriceps and hamstrings. Treatment will be given on alternate days for 4 weeks (12 sessions total).
Interventions
Conventional physiotherapy includes hot moist pack application, manual joint mobilization, stretching, and strengthening exercises for quadriceps and hamstrings. Sessions will be held on alternate days for 4 weeks (12 sessions total).
HILT will be administered using a Class IV laser applied perpendicularly at eight standardized knee points. Both analgesic and biostimulation modes will be used.. Sessions will be conducted on alternate days for 4 weeks (12 sessions total).
Eligibility Criteria
You may qualify if:
- Male and female participants aged 40-60 years.
- Diagnosed with knee osteoarthritis (Kellgren-Lawrence grade II or III).
- Knee pain for at least 3 months.
- Visual Analogue Scale (VAS) score ≥ 3.
- Willing to provide written informed consent and comply with treatment and follow-up schedule.
You may not qualify if:
- History of knee surgery or traumatic knee injury.
- Inflammatory arthritis (e.g., gout, psoriatic arthritis).
- History of cancer or psychiatric illness.
- Cognitive disorders (e.g., Parkinson's disease, Alzheimer's disease).
- Severe comorbidities limiting exercise (e.g., severe COPD, heart failure, cerebrovascular event).
- Hip or ankle joint disability.
- Intra-articular knee injection within the past 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
London Aesthetics and Rejuvenation Center
Lahore, Punjab Province, 55000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- This is a single-blind study. The outcome assessor will be blinded to group allocation, while the participants and treating physiotherapist will be aware of the intervention assigned
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2025
First Posted
May 13, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
January 15, 2027
Study Completion (Estimated)
May 10, 2027
Last Updated
May 13, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share